
Lo.Li. Pharma
We are an Italian company, based in Rome, involved in the development and marketing of medical devices and food supplements.
Scientific research, know-how and quality have always been our hallmark and enabled us to pursue our most important goal which is to create safe and effective formulations that meet the needs of medical doctors and patients.
We have been operating for years in the field of obstetrics and gynaecology, where we acquired particular recognition in the field of female and male fertility. In recent years our scientific commitment has expanded to other therapeutic areas, including endocrinology, urology and andrology. In recent years our scientific commitment has expanded to other therapeutic areas, including endocrinology, urology and andrology.
The strength of our company is the passion of its founder for scientific research, supported by a young and dynamic group, committed to guaranteeing the highest levels of quality, safety and effectiveness of the specialities developed and placed on the market. We work in a rigorous and effective way, in compliance with ethical and moral principles.
Therapeutic areas

Female fertility

Gynaecology and Obstetrics

Male Fertility and Andrology

Endocrinology

Urology
DIETARY SUPPLEMENTS
MEDICAL DEVICES
Insights
Prof. Maurizio Nordio: eccesso di estrogeni nella donna e nell’uomo, cause e approcci terapeutici
Il Prof. Maurizio Nordio, endocrinologo all’Università La Sapienza di Roma, è intervenuto ai microfoni di “La Casa della Salute” su RTV San Marino per parlare delle patologie causate dall’eccesso di...
D-Chiro-inositolo: come può aiutare nel management dei fibromi uterini?
I fibromi uterini sono tra le patologie ginecologiche più diffuse nell’universo femminile, soprattutto durante l’età riproduttiva, ma non sono tutti uguali. Spesso, uno dei principali parametri che...
PCOS: 20 anni dopo
La sindrome dell'ovaio policistico (PCOS) rappresenta una delle patologie più comuni nelle donne in età fertile. La sua prevalenza varia notevolmente, con dati che oscillano tra il 5% e il 18%...